Novel 1,2,3-triazole epicinchonas: Transitioning from organocatalysis to biological activities
| dc.contributor.author | Barrulas, Pedro | |
| dc.contributor.author | Carreiro, Elizabete | |
| dc.contributor.author | Veiros, Luis | |
| dc.contributor.author | Amorim, Ana | |
| dc.contributor.author | Gut, Giri | |
| dc.contributor.author | Rosenthal, Philip | |
| dc.contributor.author | López, Óscar | |
| dc.contributor.author | Puerta, Adrián | |
| dc.contributor.author | Padrón, José | |
| dc.contributor.author | Fernandez-Bolanos, José | |
| dc.contributor.author | Burke, Anthony | |
| dc.date.accessioned | 2021-12-03T11:06:27Z | |
| dc.date.available | 2021-12-03T11:06:27Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | A small family of novel modular monofunctional epicinchonidine- 1,2,3-triazole compounds was prepared in very good overall yield (3 steps from cinchonidine, 49–87% yield) using simple Cu(I) catalyzed click-chemistry. The objective of this study was to access their hitherto unknown catalytic role in some key organic reactions like: ketimine hydrosilylation, Michael-addition and the Biginelli reaction. This is the first report on the application of cinchonidine derived 1,2,3-triazoles in organocatalysis, and includes catalytic screening and preliminary Density Functional Theory (DFT) mechanistic studies. The new com- pounds were screened for antimalarial activity against Plasmodium fal- ciparum (W2 strain), exhibiting IC50 values in the range 2.0–6.8mM; and cholinesterase inhibition, showing activity against eqBuChE, but their main potential is for tumor anti-proliferation (showing a lowest GI50 of 8.1 mM). Gratifyingly, all our compounds were non-cytotoxic against the non-tumor healthy cell line, BJ-hTERT and they presented excellent simulated pharmacological properties. | por |
| dc.identifier.authoremail | pbarrulas@uevora.pt | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.doi | 10.1080/00397911.2021.1948575 | por |
| dc.identifier.uri | https://www.tandfonline.com/doi/full/10.1080/00397911.2021.1948575 | |
| dc.identifier.uri | http://hdl.handle.net/10174/30378 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Synthetic Communications | por |
| dc.rights | restrictedAccess | por |
| dc.subject | Organocatalysis | por |
| dc.subject | Cinchona Alkaloids | por |
| dc.subject | Click Chemistry | por |
| dc.subject | Tumor antiproliferation | por |
| dc.subject | Antimalarial | por |
| dc.subject | Cholinesterases | por |
| dc.title | Novel 1,2,3-triazole epicinchonas: Transitioning from organocatalysis to biological activities | por |
| dc.type | article |